Brief by Shorts91 Newsdesk / 08:10am on 23 Sep 2026,Wednesday India
The Supreme Court has questioned the sharp rise in prices of essential cancer medicines after being told that a drug bought by retailers for Rs 2,700 was sold with an MRP of Rs 27,000. A bench of Justices Vikram Nath and Sandeep Mehta questioned how patients could be charged 10 times the procurement cost and why authorities had not acted. The court also raised concerns over hospitals buying medicines at high prices and seeking reimbursement under government health schemes. The petitions before the court allege excessive markups, forced purchases from hospital pharmacies and limited access to cheaper alternatives. (PC: India Today)
